# US 10,245,381 B2 · Two-step auto-injection device > Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt - Number: US 10,245,381 B2 - Document ID: US10245381B2 - Status: Granted - Kind: B2 - Application number: 15/681,876 - Filed: 2017-08-21 - Published: 2019-02-21 - Granted: 2019-04-02 - Earliest claimed: 2017-08-21 - Assignees: Chalbourne Brasington - Applicants: Chalbourne Brasington - Inventors: Chalbourne Brasington - Web page: https://patentgrep.com/patent/US10245381B2 ## CPC - A61M 5/24: Ampoule syringes, i.e. syringes with needle for use in combination with replaceable ampoules or cartridges, e.g. automatic - A61M 5/2033: {Spring-loaded one-shot injectors with or without automatic needle insertion (multishot dosing syringes A61M5/31525, needle insertion only A61M5/3287)} - A61M 5/3213: {Caps placed axially onto the needle, e.g. equipped with finger protection guards (axially-extensible protective sleeves A61M5/3243)} - A61M 2005/2013: {triggering of discharging means by contact of injector with patient body} - A61M 2005/2026: {Semi-automatic, e.g. user activated piston is assisted by additional source of energy} - A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)} ## Abstract An auto-injection device for delivery of a fluid medicament is provided. The device includes an ampoule having a fluid medicament contained between first and second stoppers; a first sleeve movable along the longitudinal direction relative to the ampoule; a second sleeve at least partially surrounding the ampoule and movable along the longitudinal direction relative to the ampoule; and a needle. The first sleeve is movable along the longitudinal direction relative to the second sleeve and the ampoule between a first position and a second position. The needle is unexposed in the first position but exposed along the longitudinal direction in the second position. The second sleeve is also movable along the longitudinal direction relative to the ampoule between a first position and a second position. The needle is fluidly isolated from the medicament in the first position and is in fluid communication with the medicament in the second position. ## Claims ### Claim 1 An auto-injection device defining a longitudinal direction, the auto-injection device comprising: an ampoule, the ampoule comprising a fluid medicament contained between a first stopper located towards a proximal end of the ampoule and a second stopper located towards a distal end of the ampoule, wherein the first stopper includes a first recess located at a proximal edge of the first stopper and a second recess located at a distal edge of the first stopper, wherein the second recess is disposed between the first recess and the second stopper; a first sleeve movable along the longitudinal direction relative to the ampoule; a second sleeve at least partially surrounding the ampoule and movable along the longitudinal direction relative to the ampoule, wherein the second sleeve is movable from a proximal end of the auto-injection device towards a distal end of the auto-injection device; and a needle located at the proximal end of the auto-injection device; wherein the first sleeve is movable along the longitudinal direction relative to the second sleeve and the ampoule between a first position and a second position, wherein in the first position the needle is unexposed along the longitudinal direction and in the second position the needle is exposed along the longitudinal direction, further wherein a proximal end of the first sleeve is in direct contact with a proximal end of the second sleeve in the second position, and wherein the second sleeve is movable along the longitudinal direction relative to the ampoule between a first position and a second position, wherein in the first position the needle is fluidly isolated from the fluid medicament and in the second position the needle is in fluid communication with the fluid medicament. ### Claim 2 (depends on 1) The auto-injection device of claim 1, wherein the needle is fixed to the second sleeve. ### Claim 3 (depends on 1) The auto-injection device of claim 1, wherein a biasing element is contained within the ampoule towards the distal end of the ampoule, wherein the biasing element exerts a biasing force on the second stopper towards the first stopper. ### Claim 4 (depends on 1) The auto-injection device of claim 1, further comprising a removable safety, wherein the removable safety prevents movement of the first sleeve from the first position to the second position, prevents movement of the second sleeve from the first position to the second position, or both when not removed. ### Claim 5 (depends on 1) The auto-injection device of claim 1, wherein the first sleeve, the second sleeve, and the ampoule each comprise a plastic. ### Claim 6 (depends on 1) The auto-injection device of claim 1, wherein the ampoule is in direct contact with the second sleeve. ### Claim 7 (depends on 1) The auto-injection device of claim 1, wherein the fluid medicament contains epinephrine. ### Claim 8 (depends on 1) The auto-injection device of claim 1, wherein the auto-injection device has a length in the longitudinal direction of less than 150 millimeters. ### Claim 9 (depends on 1) The auto-injection device of claim 1, wherein the auto-injection device is a two-step fluid medicament delivery device, wherein a proximal end of the needle is configured to pierce a surface of skin in a first step and the fluid medicament is configured to be delivered in a subsequent second step. ### Claim 10 (depends on 9) The auto-injection device of claim 9, wherein, in the second step, fluid medicament is configured to be delivered when the second sleeve is in the second position. ### Claim 11 (depends on 9) The auto-injection device of claim 9, wherein a distal end of the needle is contained within the second recess when the fluid medicament is configured to be delivered in the subsequent second step. ### Claim 12 (depends on 9) The auto-injection device of claim 9, wherein, in the first step, the needle is configured to pierce the surface of skin when the first sleeve is in the second position. ### Claim 13 (depends on 12) The auto-injection device of claim 12, wherein an opening is located along the proximal end of the first sleeve, wherein the proximal end of the needle is movable through the opening when the first sleeve is moved to the second position. ### Claim 14 A two-step method for delivering a dose of fluid medicament via an auto-injection device, wherein the auto-injection device defines a longitudinal direction and comprises an ampoule containing a fluid medicament contained between a first stopper located towards a proximal end of the ampoule and a second stopper located towards a distal end of the ampoule, wherein the first stopper includes a first recess located at a proximal edge of the first stopper and a second recess located at a distal edge of the first stopper, wherein the second recess is disposed between the first recess and the second stopper; a first sleeve movable in the longitudinal direction relative to the ampoule; a second sleeve at least partially surrounding the ampoule and movable along the longitudinal direction relative to the ampoule, wherein the second sleeve is movable from a proximal end of the auto-injection device towards a distal end of the auto-injection device; and a needle located at the proximal end of the auto-injection device; the method comprising: positioning the proximal end of the auto-injection device against a surface of skin, wherein the longitudinal direction of the auto-injection device is generally perpendicular to the surface of skin; piercing the surface of skin and underlying tissue with a proximal end of the needle by pressing the proximal end of the auto-injection device against the surface of skin until the first sleeve moves from a first position to a second position in a first step, wherein a proximal end of the first sleeve is in direct contact with a proximal end of the second sleeve in the second position; and delivering the fluid medicament by pressing the proximal end of the auto-injection device against the surface of skin until the second sleeve moves from a first position to a second position in a second step. ### Claim 15 (depends on 14) The method of claim 14, wherein the proximal end of the second sleeve contacts the proximal end of the ampoule when the second sleeve is in the second position. ### Claim 16 (depends on 14) The method of claim 14, wherein a distal end of the needle is contained within the second recess when the fluid medicament is delivered. ### Claim 17 (depends on 14) The method of claim 14, wherein the proximal end of the first sleeve includes an opening covered with a material to maintain sterility of the auto-injection device prior to use, wherein the material is removed prior to positioning the proximal end of the auto-injection device against the surface of skin, or wherein the material is pierced by the needle by pressing the proximal end of the auto-injection device against the surface of skin until the first sleeve moves from the first position to the second position in the first step. ### Claim 18 (depends on 14) The method of claim 14, wherein a removable safety prevents the first sleeve from sliding against the second sleeve, prevents the second sleeve from sliding against the ampoule, or both, wherein the removable safety is removed prior to positioning the proximal end of the auto-injection device against the surface of skin. ### Claim 19 (depends on 14) The method of claim 14, wherein a biasing element is contained within the ampoule towards the distal end of the ampoule, wherein the biasing element exerts a biasing force on the second stopper towards the first stopper to facilitate delivery of the fluid medicament when the second sleeve is in the second position. ### Claim 20 (depends on 14) The method of claim 14, wherein the fluid medicament contains epinephrine.